Artema Therapeutics began with a desire to cure a loved one with an inherited retinal disease. We were searching for a solution for one person, and ended up creating a therapy that will help stop the loss of vision in hundreds of children and give them a fulfilling future with healthy vision. Our next step is to create therapies for other congenital eye disorders to ensure a happy future for patients with monogenic diseases of the eye.
Our company was founded to create a cure for human vision diseases that do not currently have therapies. To achieve this goal, we engage leading scientific groups in the fields of genome editing and ophthalmology from around the world.
